What companies are LNAI's competitors?

Lunai Bioworks Inc. (LNAI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does LNAI compare to its peers?

The peer comparison table on this page shows Lunai Bioworks Inc. (LNAI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does LNAI operate in?

Lunai Bioworks Inc. (LNAI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

LNAI (Lunai Bioworks Inc.) is a recent IPO.

It began trading on September 30, 2025, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.

LNAI

Lunai Bioworks Inc.

NASDAQ·Biotechnology · Healthcare

$2.40$0.20+9.09%

After hours·$2.34−2.50%

Market cap$10.88M·Market closed·Aug 26 8:00 PM UTC

Frequently Asked Questions About LNAI

What companies are LNAI's competitors?: Lunai Bioworks Inc. (LNAI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does LNAI compare to its peers?: The peer comparison table on this page shows Lunai Bioworks Inc. (LNAI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does LNAI operate in?: Lunai Bioworks Inc. (LNAI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

LNAI (Lunai Bioworks Inc.) is a recent IPO.

LNAI

Lunai Bioworks Inc.

NASDAQ·Biotechnology · Healthcare

$2.40$0.20+9.09%

After hours·$2.34−2.50%

Market cap$10.88M·Market closed·Aug 26 8:00 PM UTC

Peers


ANL	Adlai Nortye Ltd.	$15.06	$799.4M
THAR	Tharimmune, Inc.	$3.54	$139.9M
ADAP	Adaptimmune Therapeutics plc	$0.05	$75.2M
APLM	Apollomics, Inc.	$26.20	$57.5M
LPCN	Lipocine Inc.	$2.15	$17.7M
BLRX	BioLineRx Ltd.	$2.70	$11.7M
ICU	SeaStar Medical Holding Corporation	$3.12	$8.9M
GOVX	GeoVax Labs, Inc.	$0.63	$4.6M
MBRX	Moleculin Biotech, Inc.	$0.60	$3.2M
ERNA	Ernexa Therapeutics Inc.	$4.89	$1.5M

Frequently Asked Questions About LNAI

What companies are LNAI's competitors?: Lunai Bioworks Inc. (LNAI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does LNAI compare to its peers?: The peer comparison table on this page shows Lunai Bioworks Inc. (LNAI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does LNAI operate in?: Lunai Bioworks Inc. (LNAI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.